BioGaia AB (publ)
BIOG-B
Peringkat dalam Saham
#7837
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
Harga Saham
$13.86
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$1.37B
Perubahan (1 hari)
0.65%
Perubahan (1 tahun)
23.21%
Negara
SE
Perdagangan BioGaia AB (publ) (BIOG-B)
Kategori
Healthcare
Kapitalisasi pasar dari BioGaia AB (publ)(BIOG-B)
Kapitalisasi Pasar: $1.37B
Per October 2026, BioGaia AB (publ) memiliki kapitalisasi pasar sebesar $1.37B. Ini menjadikan BioGaia AB (publ) sebagai perusahaan 7837th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar BioGaia AB (publ) dari 2015 hingga 2026
BIOG-B dibandingkan dengan 5 teratas stocks paling populer
